Existence of a hypercoagulability state prior to prosthetic hip or knee surgery.
Iturbe
T
T
Cornudella
R
R
de Miguel
R
R
Olave
T
T
Moreno
J A
JA
Gutiérrez
M
M
D000368:Aged; D000990:Antithrombin III / Q000032:analysis*; D019644:Arthroplasty, Replacement, Hip; D019645:Arthroplasty, Replacement, Knee; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000032:analysis*; D010447:Peptide Hydrolases / Q000032:analysis*; D011183:Postoperative Complications / Q000517:prevention & control; D011237:Predictive Value of Tests; D011292:Premedication; D011300:Preoperative Care; D011516:Prothrombin / Q000032:analysis*; D019851:Thrombophilia / Q000097:blood / Q000175:diagnosis*; D013927:Thrombosis / Q000517:prevention & control
D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; D010446:Peptide Fragments; C046193:antithrombin III-protease complex; C036309:fibrin fragment D; C045879:prothrombin fragment 1.2; D000990:Antithrombin III; D011516:Prothrombin; D010447:Peptide Hydrolases